Tapan Patel, MD
Otolaryngology · North Haven, CTNPI 1225424252
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,774 of the $4,060 with a category attached, or 68.3%. AbbVie accounts for 68.3% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2021 at $3,171 and has fallen 98.9% since, to $34 in 2025.
Across 16 payments — averaging $253.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Stryker$431
- Acclarent, Inc$294
- Integra Lifesciences Corporation$180
- Neurent Medical Limited$130
- Xoran Technologies LLC$83
- plus $168 from 4 others
What the payments were for
- Consulting fees$2,77468%
- Food & beverage$91523%
- Education$3719%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 2 | $2,774 |
| Stryker | 2 | $431 |
| Acclarent, Inc | 2 | $294 |
| Integra Lifesciences Corporation | 2 | $180 |
| Neurent Medical Limited | 2 | $130 |
| Xoran Technologies LLC | 1 | $83 |
| GSK | 1 | $79 |
| Optinose US, Inc. | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Medtronic | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$2,774
- UNIVERSAL MANDIBLE$371
- TruDi Nav Cable$294
- Acclarent Aera$166
- Inspira Air$166
- RELIEVA SPINPLUS NAV$166
- TruDi Probe$166
- NEUROMARK Device$118
- NEUROMARK Radiofrequency Console$118
How this compares
$4,060 in reported general payments places this provider in the 75th percentile of 119 otolaryngology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 84 | $4,348 |
| Omeprazole | 164 | $3,006 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 18 | $2,134 |
| Azelastine Hcl | 62 | $1,684 |
| Mometasone Furoate | 30 | $1,399 |
| Fluticasone Propionate | 88 | $1,258 |
| Fluocinolone Acetonide Oil | 26 | $1,011 |
| Famotidine | 59 | $734 |
| Doxycycline Hyclate | 67 | $492 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 55 | $328 |
| Prednisone | 108 | $271 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 35 | $111 |
| Methylprednisolone | 23 | $107 |
| Mupirocin | 23 | $91 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 24 | $89 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in North Haven
- Paul AlbertiNorth Haven$5K
- Sara PaiNew Haven$160K
- Richard ManesNew Haven$67K
- Howard StupakWestport$48K
- Belachew TessemaFarmington$45K
- Seth BrownFarmington$39K
- Howard BoeyNew Haven$19K
- Mahesh BhayaWaterbury$11K
- Neil SchiffWaterbury$10K
- Benjamin WycherlyFarmington$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.